Nathaniel works with companies of all sizes, from start-ups to large pharmaceutical companies, to secure strong worldwide patent rights. He has drafted applications relating to biomanufacturing, antigen-binding compositions, bio-marker guided therapies, and nutraceutical sugar compositions. Nathaniel’s practice focuses on managing portfolios relating to antibody therapeutics, biologics production, and microbiome modification. He also provides technical support, due diligence review, and freedom to operate analyses for clients in a variety of areas of the life sciences.

Prior to joining L&A, Nathaniel worked in the patent group of a global law firm doing patent prosecution. As a post-doctoral associate at MIT, Nathaniel developed online biology courses on the edX learning platform covering a wide array of life science topics, including: introductory, computational, and molecular biology. During his Ph.D. research, Nathaniel studied how ultraviolet light contributed to cataract development by monitoring the protein aggregation and structural conformation of human lens proteins.

Education and Prior Experience

  • Suffolk University Law School, Candidate for J.D. (expected 2021)
  • Massachusetts Institute of Technology, Ph.D., Biology
  • Brandeis University, M.S., Biochemistry, summa cum laude, Phi Beta Kappa
  • Brandeis University, B.S., Biochemistry, summa cum laude, Phi Beta Kappa

Admissions, Memberships, and Acknowledgements

  • Registered to practice before the U.S. Patent and Trademark Office